RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 16
SP 20
OP 20
DO 10.1177/155989771216008
UL http://mdc.sagepub.com/content/12/16/20.abstract
AB Insulin degludec is superior to sitagliptin in improving glycemic control in patients with type 2 diabetes mellitus uncontrolled by oral antidiabetic drugs (OADs). This article discusses the results of the comparison of NN1250 with Sitagliptin in Subjects with Type 2 Diabetes Never Treated with Insulin [BEGIN®: EARLY; NCT01046110] trial that compared basal insulin with a dipeptidyl peptidase-4 inhibitor as an add-on to OADs.